Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037463 · ClinicalTrials.gov registry record
Measuring Parkinson's Disease With Tear Fluid
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 205
- Enrollment target
NCT03037463 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 205 participants.
The verdict
NCT03037463 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether tear secretion in patients with Parkinson's disease will be altered to exhibit a characteristic or diagnostic biomarker profile, that will be reflected in changes in the protein composition of tear fluid, which can be measured relatively easily, cost-effectively, and non-invasively. Tear fluid samples will be collected from Parkinson's patients, and through biochemical assays, the profile of proteins in tears will be characterized and compared to that from control subjects. The profiles will be analyzed with respect to any differences between Parkinson's patients and control subjects. If differences appear, the levels of these potential biomarkers in Parkinson's patients will be compared to the severity of their disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03037463
The ClinicalTrials.gov registry entry for NCT03037463 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03037463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03037463 about?
NCT03037463 is a clinical study titled "Measuring Parkinson's Disease With Tear Fluid". The purpose of this study is to assess whether tear secretion in patients with Parkinson's disease will be altered to exhibit a characteristic or diagnostic biomarker profile, that will be reflected in changes in the protein composition of tear fluid, which can be measured relatively easily, cost-ef...
What is the current status of trial NCT03037463?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2017-01. Estimated completion is 2022-03.
Who is sponsoring clinical trial NCT03037463?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.